COST-EFFECTIVENESS ANALYSIS OF ALECTINIB COMPARED TO CHEMOTHERAPY FOR
THE TREATMENT OF TREATMENT-NAIVE PATIENTS WITH ALK POSITIVE LOCALLY
ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN GREECE
COST-EFFECTIVENESS ANALYSIS OF ALECTINIB COMPARED TO CHEMOTHERAPY FOR THE TREATMENT OF TREATMENT-NAIVE PATIENTS WITH ALK POSITIVE LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN GREECE